» Articles » PMID: 19706422

Human Deoxyhypusine Hydroxylase, an Enzyme Involved in Regulating Cell Growth, Activates O2 with a Nonheme Diiron Center

Overview
Specialty Science
Date 2009 Aug 27
PMID 19706422
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Deoxyhypusine hydroxylase is the key enzyme in the biosynthesis of hypusine containing eukaryotic translation initiation factor 5A (eIF5A), which plays an essential role in the regulation of cell proliferation. Recombinant human deoxyhypusine hydroxylase (hDOHH) has been reported to have oxygen- and iron-dependent activity, an estimated iron/holoprotein stoichiometry of 2, and a visible band at 630 nm responsible for the blue color of the as-isolated protein. EPR, Mössbauer, and XAS spectroscopic results presented herein provide direct spectroscopic evidence that hDOHH has an antiferromagnetically coupled diiron center with histidines and carboxylates as likely ligands, as suggested by mutagenesis experiments. Resonance Raman experiments show that its blue chromophore arises from a (mu-1,2-peroxo)diiron(III) center that forms in the reaction of the reduced enzyme with O2, so the peroxo form of hDOHH is unusually stable. Nevertheless we demonstrate that it can carry out the hydroxylation of the deoxyhypusine residue present in the elF5A substrate. Despite a lack of sequence similarity, hDOHH has a nonheme diiron active site that resembles both in structure and function those found in methane and toluene monooxygenases, bacterial and mammalian ribonucleotide reductases, and stearoyl acyl carrier protein Delta9-desaturase from plants, suggesting that the oxygen-activating diiron motif is a solution arrived at by convergent evolution. Notably, hDOHH is the only example thus far of a human hydroxylase with such a diiron active site.

Citing Articles

eIF5A downregulated by mechanical overloading delays chondrocyte senescence and osteoarthritis by regulating the CREBBP-mediated Notch pathway.

Huang J, Zheng J, Yin J, Lin R, Wu J, Xu H Bone Joint Res. 2025; 14(2):124-135.

PMID: 39973340 PMC: 11840444. DOI: 10.1302/2046-3758.142.BJR-2024-0288.R1.


Proteome-wide tagging with an HO biosensor reveals highly localized and dynamic redox microenvironments.

Kritsiligkou P, Bosch K, Shen T, Meurer M, Knop M, Dick T Proc Natl Acad Sci U S A. 2023; 120(48):e2314043120.

PMID: 37991942 PMC: 10691247. DOI: 10.1073/pnas.2314043120.


The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases.

Kontoghiorghes G Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513928 PMC: 10384919. DOI: 10.3390/ph16071016.


New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer.

Kontoghiorghes G Int J Mol Sci. 2022; 23(22).

PMID: 36430469 PMC: 9696688. DOI: 10.3390/ijms232213990.


Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.

Kontoghiorghes G Int J Mol Sci. 2022; 23(12).

PMID: 35743183 PMC: 9223898. DOI: 10.3390/ijms23126735.


References
1.
Park M, Wolff E, Lee Y, Folk J . Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines. J Biol Chem. 1994; 269(45):27827-32. View

2.
Krebs C, Herlihy K, Edmondson D, Theil E, Huynh B, Loehr T . The ferroxidase reaction of ferritin reveals a diferric mu-1,2 bridging peroxide intermediate in common with other O2-activating non-heme diiron proteins. Biochemistry. 1999; 38(17):5290-5. DOI: 10.1021/bi990095l. View

3.
Park M, Cooper H, Folk J . The biosynthesis of protein-bound hypusine (N epsilon -(4-amino-2-hydroxybutyl)lysine). Lysine as the amino acid precursor and the intermediate role of deoxyhypusine (N epsilon -(4-aminobutyl)lysine). J Biol Chem. 1982; 257(12):7217-22. View

4.
Notomista E, Lahm A, Di Donato A, Tramontano A . Evolution of bacterial and archaeal multicomponent monooxygenases. J Mol Evol. 2003; 56(4):435-45. DOI: 10.1007/s00239-002-2414-1. View

5.
Dixon M . The acceptor specificity of flavins and flavoproteins. I. Techniques for anaerobic spectrophotometry. Biochim Biophys Acta. 1971; 226(2):241-58. DOI: 10.1016/0005-2728(71)90092-2. View